Basal Tryptase Levels Can Predict Clinical Severity in Hymenoptera Venom Anaphylaxis and Ischemic Cardiovascular Disorders

J Investig Allergol Clin Immunol. 2019 Apr;29(2):162-164. doi: 10.18176/jiaci.0363.

Authors

L Farioli¹, L M Losappio², J W Schroeder², D Preziosi², J Scibilia², L Caron², M Nichelatti³, E A Pastorello²

Affiliations

¹ Department of Laboratory Medicine, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
² Department of Allergology and Immunology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
³ Biostatistics Service, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

PMID: 31017123
DOI: 10.18176/jiaci.0363

No abstract available

Keywords: Acute coronary syndrome; Hymenoptera venom allergy; Major cardiovascular events; Mast cells; Tryptase.

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Allergens / adverse effects*
Anaphylaxis / blood
Anaphylaxis / enzymology*
Animals
Arthropod Venoms / adverse effects*
Biomarkers / blood
Child
Child, Preschool
Female
Humans
Hymenoptera / immunology*
Ischemia / blood
Ischemia / enzymology*
Male
Middle Aged
Severity of Illness Index
Tryptases / blood*
Young Adult

Substances

Allergens
Arthropod Venoms
Biomarkers
Tryptases